Retatrutide is a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors , which are all involved in regulating metabolism and energy use
TABLE 3 Results of disproportionate analysis of AEs associated with biliary disorders of GLP-1 RAs and DPP-4 inhibitors at the SMQ level
For example, in April of this year, The New York Times reported on the case of Renata Lavach-Savy, who became malnourished on the drug despite weighing over 200 pounds
Long gaps between meals can trigger headaches, especially in people who are sensitive to fasting
If there is significant extra skin or a true apron of tissue, non-surgical methods will not remove it completely
This article explains what retatrutide is, how it works, its current regulatory status, and what anyone considering involvement in a clinical trial should know about safety and side effects